Hemophilia B, Factor IX Gene Known Mutation Screening
Method Description Describes how the test is performed and provides a method-specific reference
Direct mutation analysis of leukocyte genomic DNA performed by PCR amplification of fIX gene, followed by fluorescent DNA sequencing analysis utilizing Applied Biosystem Inc. (ABI):single region.(Costa JM, Ernault P, Vidaud D, et al: Fast and efficient mutation detection method using multiplex PCR and cycle sequencing--application to haemophilia B. Thromb Haemost 2000 Feb;83:244-247; Kaiser RJ, MacKellar SL, Vinayak RS, et al: Specific-primer-directed DNA sequencing using automated fluorescence detection. Nucleic Acids Res 1989 Aug 11;17:6087-6102)
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday